RLAY – relay therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Down -23.95% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround [Yahoo! Finance]
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target raised by analysts at HC Wainwright from $19.00 to $20.00. They now have a "buy" rating on the stock.
Relay Therapeutics to Participate in Upcoming Investor Conferences
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights [Yahoo! Finance]
Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights
Form SC 13G/A Relay Therapeutics, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Form 10-Q Relay Therapeutics, Inc. For: Sep 30
Form 8-K Relay Therapeutics, Inc. For: Nov 06
Form 4 Relay Therapeutics, Inc. For: Oct 28 Filed by: Rahmer Peter
Form 4 Relay Therapeutics, Inc. For: Oct 28 Filed by: Bergstrom Donald A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.